secwatch.observer — SEC 8-K summary
======================================

Issuer:     Endo LP (—)
CIK:        0002008861
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0000950103-24-012639
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Endo CEO Blaise Coleman departs; Board member Scott Hirsch named Interim CEO
----------------------------------------------------------------------------

- Blaise Coleman to step down as President & CEO and from the Board effective August 29, 2024; no disagreements cited.
- Scott Hirsch, Board member since April 2024, appointed Interim CEO effective August 29; search underway for permanent CEO.
- Hirsch receives $250k/month base salary ($400k/month if still interim after Dec 31, 2024); no severance or incentive plan eligibility.
- Committee changes: Hirsch leaves Compensation & Compliance; Paul Herendeen joins Compensation, Sophia Langlois chairs it and joins Compliance.
- Board retained Spencer Stuart to assist CEO search; company reiterates focus on relisting and portfolio execution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/0000950103-24-012639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/dp217093_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-012639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer